Generation of pluripotent stem cells via protein transduction

International Journal of Developmental Biology

Volumn 58, Issue 1, 2014, Pages 21-26

  Li, Xia ^a   Zhang, Pengfei ^a   Wei, Chao ^a   Zhang, Yunhai ^a  

^a ANHUI AGRICULTURAL UNIVERSITY   (China)

Author keywords

Immunogenicity; Induced pluripotent stem cell; Protein; Reprogramming; Small molecule

Indexed keywords

CELL PENETRATING PEPTIDE; HEPARIN; KRUPPEL LIKE FACTOR 4; MYC PROTEIN; OCTAMER TRANSCRIPTION FACTOR 4; POLYINOSINIC POLYCYTIDYLIC ACID; PROTEIN; STREPTOLYSIN O; TRANSACTIVATOR PROTEIN; TRANSCRIPTION FACTOR SOX2; VALPROIC ACID;

EPITHELIAL MESENCHYMAL TRANSITION; ESCHERICHIA COLI; GENE EXPRESSION; GENE EXPRESSION SYSTEM; HUMAN; IMMUNOGENICITY; MEMBRANE TRANSPORT; NONHUMAN; NUCLEAR LOCALIZATION SIGNAL; NUCLEAR REPROGRAMMING; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; PROTEIN PROCESSING; PROTEIN TRANSPORT; REVIEW; SOMATIC CELL; ANIMAL; CELL DIFFERENTIATION; CYTOLOGY; METABOLISM; REGENERATIVE MEDICINE; SHEEP;

ANIMALS; CELL DIFFERENTIATION; CELLULAR REPROGRAMMING; HUMANS; PLURIPOTENT STEM CELLS; PROTEINS; REGENERATIVE MEDICINE; SHEEP;

EID: 84899753262     PISSN: 02146282     EISSN: None     Source Type: Journal    
DOI: 10.1387/ijdb.140007XL     Document Type: Review

References (71)

1. ARAKI, R., UDA, M., HOKI, Y., SUNAYAMA, M., NAKAMURA, M., ANDO, S., SUGIURA, M., IDENO, H., SHIMADA, A., NIFUJI, A. et al., (2013). Negligible immunogenicity of terminally differentiated cells derived from induced pluripotent or embryonic stem cells. Nature 494: 100-104.
2. BAN, H., NISHISHITA, N., FUSAKI, N., TABATA, T., SAEKI, K., SHIKAMURA, M., TAKADA, N., INOUE, M., HASEGAWA, M., KAWAMATA, S. et al., (2011). Efficient generation of transgene-free human induced pluripotent stem cells (iPSCs) by temperature-sensitive Sendai virus vectors. Proc Natl Acad Sci USA 108: 14234-14239.
3. BECKER-HAPAK, M., MCALLISTER, S.S. and DOWDY, S.F. (2001). TAT-mediated protein transduction into mammalian cells. Methods 24: 247-256.
4. BEERENS, A.M., AL HADITHY, A.F., ROTS, M.G. and HAISMA, H.J. (2003). Protein transduction domains and their utility in gene therapy. Curr Gene Ther 3: 486-494.
5. BHAKDI, S., TRANUM-JENSEN, J. and SZIEGOLEIT, A. (1985). Mechanism of membrane damage by streptolysin-O. Infect Immun 47: 52-60.
6. BUI, H.T., KWON, D.N., KANG, M.H., OH, M.H., PARK, M.R., PARK, W.J., PAIK, S.S., VAN THUAN, N. and KIM, J.H. (2012). Epigenetic reprogramming in somatic cells induced by extract from germinal vesicle stage pig oocytes. Development 139: 4330-4340.
7. CHEN, J., GUO, L., ZHANG, L., WU, H., YANG, J., LIU, H., WANG, X., HU, X., GU, T., ZHOU, Z. et al., (2013). Vitamin C modulates TET1 function during somatic cell reprogramming. Nat Genet 45: 1504-1509.
8. CHO, H.J., LEE, C.S., KWON, Y.W., PAEK, J.S., LEE, S.H., HUR, J., LEE, E.J., ROH, T.Y., CHU, I.S., LEEM, S.H. et al., (2010). Induction of pluripotent stem cells from adult somatic cells by protein-based reprogramming without genetic manipulation. Blood 116: 386-395.
9. CHO, S.J., CHOI, H.W., CHO, J., JUNG, S., SEO, H.G. and DO, J.T. (2013). Activation of pluripotency genes by a nanotube-mediated protein delivery system. Mol Reprod Dev 80: 1000-1008.
10. CHUGH, A., EUDES, F. and SHIM, Y.S. (2010). Cell-penetrating peptides: Nanocarrier for macromolecule delivery in living cells. IUBMB Life 62: 183-193.
11. COSTA, Y., DING, J., THEUNISSEN, T.W., FAIOLA, F., HORE, T.A., SHLIAHA, P.V., FIDALGO, M., SAUNDERS, A., LAWRENCE, M., DIETMANN, S. et al., (2013). NANOG-dependent function of TET1 and TET2 in establishment of pluripotency. Nature 495: 370-374.
12. DHODAPKAR, K.M., FELDMAN, D., MATTHEWS, P., RADFAR, S., PICKERING, R., TURKULA, S., ZEBROSKI, H. and DHODAPKAR, M.V. (2010). Natural immunity to pluripotency antigen OCT4 in humans. Proc Natl Acad Sci USA 107: 8718-8723.
13. ESTEBAN, M.A., WANG, T., QIN, B., YANG, J., QIN, D., CAI, J., LI, W., WENG, Z., CHEN, J., NI, S. et al., (2010). Vitamin C enhances the generation of mouse and human induced pluripotent stem cells. Cell Stem Cell 6: 71-79.
14. FRANKEL, A.D., BREDT, D.S. and PABO, C.O. (1988). Tat protein from human immunodeficiency virus forms a metal-linked dimer. Science 240: 70-73.
15. FRANKEL, A.D. and PABO, C.O. (1988). Cellular uptake of the tat protein from human immunodeficiency virus. Cell 55: 1189-1193.
16. FREBERG, C.T., DAHL, J.A., TIMOSKAINEN, S. and COLLAS, P. (2007). Epigenetic reprogramming of OCT4 and NANOG regulatory regions by embryonal carcinoma cell extract. Mol Biol Cell 18: 1543-1553.
17. GANIER, O., BOCQUET, S., PEIFFER, I., BROCHARD, V., ARNAUD, P., PUY, A., JOUNEAU, A., FEIL, R., RENARD, J.P. and MECHALI, M. (2011). Synergic reprogramming of mammalian cells by combined exposure to mitotic Xenopus egg extracts and transcription factors. Proc Natl Acad Sci USA 108: 17331-17336.
18. GEOGHEGAN, E. and BYRNES, L. (2008). Mouse induced pluripotent stem cells. Int J Dev Biol 52: 1015-1022.
19. GUHA, P., MORGAN, J.W., MOSTOSLAVSKY, G., RODRIGUES, N.P. and BOYD, A.S. (2013). Lack of immune response to differentiated cells derived from syngeneic induced pluripotent stem cells. Cell Stem Cell 12: 407-412.
20. GUMP, J.M. and DOWDY, S.F. (2007). TAT transduction: the molecular mechanism and therapeutic prospects. Trends Mol Med 13: 443-448.
21. HOU, P., LI, Y., ZHANG, X., LIU, C., GUAN, J., LI, H., ZHAO, T., YE, J., YANG, W., LIU, K. et al., (2013). Pluripotent stem cells induced from mouse somatic cells by small-molecule compounds. Science 341: 651-654.
22. HUANGFU, D., MAEHR, R., GUO, W., EIJKELENBOOM, A., SNITOW, M., CHEN, A.E. and MELTON, D.A. (2008a). Induction of pluripotent stem cells by defined factors is greatly improved by small-molecule compounds. Nat Biotechnol 26: 795-797.
23. HUANGFU, D., OSAFUNE, K., MAEHR, R., GUO, W., EIJKELENBOOM, A., CHEN, S., MUHLESTEIN, W. and MELTON, D.A. (2008b). Induction of pluripotent stem cells from primary human fibroblasts with only Oct4 and Sox2. Nat Biotechnol 26: 1269-1275.
24. JIA, F., WILSON, K.D., SUN, N., GUPTA, D.M., HUANG, M., LI, Z., PANETTA, N.J., CHEN, Z.Y., ROBBINS, R.C., KAY, M.A. et al., (2010). A nonviral minicircle vector for deriving human iPS cells. Nat Methods 7: 197-199.
25. KHAN, M., ANG, C.Y., WIRADHARMA, N., YONG, L.K., LIU, S., LIU, L., GAO, S. and YANG, Y.Y. (2012). Diaminododecane-based cationic bolaamphiphile as a non-viral gene delivery carrier. Biomaterials 33: 4673-4680.
26. KHAN, M., NARAYANAN, K., LU, H., CHOO, Y., DU, C., WIRADHARMA, N., YANG, Y.-Y. and WAN, A.C.A. (2013). Delivery of reprogramming factors into fibroblasts for generation of non-genetic induced pluripotent stem cells using a cationic bolaamphiphile as a non-viral vector. Biomaterials 34: 5336-5343.
27. KIM, D., KIM, C.H., MOON, J.I., CHUNG, Y.G., CHANG, M.Y., HAN, B.S., KO, S., YANG, E., CHA, K.Y., LANZA, R. et al., (2009). Generation of Human Induced Pluripotent Stem Cells by Direct Delivery of Reprogramming Proteins. Cell Stem Cell 4: 472-476.
28. LEE, J., SAYED, N., HUNTER, A., AU, K.F., WONG, W.H., MOCARSKI, E.S., PERA, R.R., YAKUBOV, E. and COOKE, J.P. (2012). Activation of Innate Immunity Is Required for Efficient Nuclear Reprogramming. Cell 151: 547-558.
29. LI, R., LIANG, J., NI, S., ZHOU, T., QING, X., LI, H., HE, W., CHEN, J., LI, F., ZHUANG, Q. et al., (2010). A mesenchymal-to-epithelial transition initiates and is required for the nuclear reprogramming of mouse fibroblasts. Cell Stem Cell 7: 51-63.
30. LIN, T., AMBASUDHAN, R., YUAN, X., LI, W., HILCOVE, S., ABUJAROUR, R., LIN, X., HAHM, H.S., HAO, E., HAYEK, A. et al., (2009). A chemical platform for improved induction of human iPSCs. Nat Methods 6: 805-808.
31. LIU, X., SUN, H., QI, J., WANG, L., HE, S., LIU, J., FENG, C., CHEN, C., LI, W., GUO, Y. et al., (2013). Sequential introduction of reprogramming factors reveals a time-sensitive requirement for individual factors and a sequential EMT-MET mechanism for optimal reprogramming. Nat Cell Biol 15: 829-838.
32. MALI, P., CHOU, B.K., YEN, J., YE, Z., ZOU, J., DOWEY, S., BRODSKY, R.A., OHM, J.E., YU, W., BAYLIN, S.B. et al., (2010). Butyrate greatly enhances derivation of human induced pluripotent stem cells by promoting epigenetic remodeling and the expression of pluripotency-associated genes. Stem Cells 28: 713-720.
33. MATSUSHITA, M., TOMIZAWA, K., MORIWAKI, A., LI, S.T., TERADA, H. and MATSUI, H. (2001). A high-efficiency protein transduction system demonstrating the role of PKA in long-lasting long-term potentiation. J Neurosci 21: 6000-6007.
34. MURRIEL, C.L. and DOWDY, S.F. (2006). Influence of protein transduction domains on intracellular delivery of macromolecules. Expert Opin Drug Deliv 3: 739-746.
35. NEMES, C., VARGA, E., POLGAR, Z., KLINCUMHOM, N., PIRITY, M.K. and DINNYES, A. (2013). Generation of Mouse Induced Pluripotent Stem Cells by Protein Transduction. Tissue Eng Part C Methods 12: 12.
36. NISHIGAKI, T., TERAMURA, Y., NASU, A., TAKADA, K., TOGUCHIDA, J. and IWATA, H. (2011). Highly efficient cryopreservation of human induced pluripotent stem cells using a dimethyl sulfoxide-free solution. Int J Dev Biol 55: 305-311.
37. OKITA, K., HONG, H., TAKAHASHI, K. and YAMANAKA, S. (2010). Generation of mouse-induced pluripotent stem cells with plasmid vectors. Nat Protoc 5: 418-428.
38. OKITA, K., ICHISAKA, T. and YAMANAKA, S. (2007). Generation of germline-competent induced pluripotent stem cells. Nature 448: 313-U1.
39. PAN, C., LU, B., CHEN, H. and BISHOP, C.E. (2010). Reprogramming human fibroblasts using HIV-1 TAT recombinant proteins OCT4, SOX2, KLF4 and c-MYC. Mol Biol Rep 37: 2117-2124.
40. PAN, G., QIN, B., LIU, N., SCHOLER, H.R. and PEI, D. (2004). Identification of a nuclear localization signal in OCT4 and generation of a dominant negative mutant by its ablation. J Biol Chem 279: 37013-37020.
41. RAJASINGH, J., LAMBERS, E., HAMADA, H., BORD, E., THORNE, T., GOUKASSIAN, I., KRISHNAMURTHY, P., ROSEN, K.M., AHLUWALIA, D., ZHU, Y. et al., (2008). Cell-free embryonic stem cell extract-mediated derivation of multipotent stem cells from NIH3T3 fibroblasts for functional and anatomical ischemic tissue repair. Circ Res 102: 15.
42. ROMANOS, M.A., SCORER, C.A. and CLARE, J.J. (1992). Foreign gene expression in yeast: a review. Yeast 8: 423-488.
43. SANGES, D. and COSMA, M.-P. (2010). Reprogramming cell fate to pluripotency: the decision-making signalling pathways. Int J Dev Biol 54: 1575-1587.
44. SILVA, J., NICHOLS, J., THEUNISSEN, T.W., GUO, G., VAN OOSTEN, A.L., BARRANDON, O., WRAY, J., YAMANAKA, S., CHAMBERS, I. and SMITH, A. (2009). Nanog is the gateway to the pluripotent ground state. Cell 138: 722-737.
45. SINGHAL, N., GRAUMANN, J., WU, G., ARAUZO-BRAVO, M.J., HAN, D.W., GREBER, B., GENTILE, L., MANN, M. and SCHOLER, H.R. (2010). Chromatin-Remodeling Components of the BAF Complex Facilitate Reprogramming. Cell 141: 943-955.
46. STADTFELD, M., NAGAYA, M., UTIKAL, J., WEIR, G. and HOCHEDLINGER, K. (2008). Induced pluripotent stem cells generated without viral integration. Science 322: 945-949.
47. TAKAHASHI, K. and YAMANAKA, S. (2006). Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126: 663-676.
48. TANG, Y., LIN, C.J. and TIAN, X.C. (2011). Functionality and transduction condition evaluation of recombinant Klf4 for improved reprogramming of iPS cells. Cellular Reprogramming 13: 99-112.
49. TARANGER, C.K., NOER, A., SORENSEN, A.L., HAKELIEN, A.M., BOQUEST, A.C. and COLLAS, P. (2005). Induction of dedifferentiation, genomewide transcriptional programming, and epigenetic reprogramming by extracts of carcinoma and embryonic stem cells. Mol Biol Cell 16: 5719-5735.
50. THIER, M., MUNST, B. and EDENHOFER, F. (2010). Exploring refined conditions for reprogramming cells by recombinant Oct4 protein. Int J Dev Biol 54: 1713-1721.
51. THIER, M., MUNST, B., MIELKE, S. and EDENHOFER, F. (2012). Cellular reprogramming employing recombinant sox2 protein. Stem Cells Int 549846: 29.
52. TOTONCHI, M., TAEI, A., SEIFINEJAD, A., TABEBORDBAR, M., RASSOULI, H., FARROKHI, A., GOURABI, H., AGHDAMI, N., HOSSEINI SALEKDEH, G. and BAHARVAND, H. (2010). Feeder-and serum-free establishment and expansion of human induced pluripotent stem cells. Int J Dev Biol 54: 877-886.
53. TYAGI, M., RUSNATI, M., PRESTA, M. and GIACCA, M. (2001). Internalization of HIV-1 tat requires cell surface heparan sulfate proteoglycans. J Biol Chem 276: 3254-3261.
54. WADIA, J.S., STAN, R.V. and DOWDY, S.F. (2004). Transducible TAT-HA fusogenic peptide enhances escape of TAT-fusion proteins after lipid raft macropinocytosis. Nat Med 10: 310-315.
55. WANG, J., GU, Q., HAO, J., JIA, Y., XUE, B., JIN, H., MA, J., WEI, R., HAI, T., KONG, Q. et al., (2013). Tbx3 and Nr5alpha2 play important roles in pig pluripotent stem cells. Stem Cell Rev 9: 700-708.
56. WANG, T., CHEN, K., ZENG, X., YANG, J., WU, Y., SHI, X., QIN, B., ZENG, L., ESTEBAN, M.A., PAN, G. et al., (2011). The histone demethylases Jhdm1a/1b enhance somatic cell reprogramming in a vitamin-C-dependent manner. Cell Stem Cell 9: 575-587.
57. WANG, Y. and ADJAYE, J. (2011). A cyclic AMP analog, 8-Br-cAMP, enhances the induction of pluripotency in human fibroblast cells. Stem Cell Rev 7: 331-341.
58. WARREN, L., MANOS, P.D., AHFELDT, T., LOH, Y.H., LI, H., LAU, F., EBINA, W., MANDAL, P.K., SMITH, Z.D., MEISSNER, A. et al., (2010). Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA. Cell Stem Cell 7: 618-630.
59. WILMUT, I., SCHNIEKE, A.E., MCWHIR, J., KIND, A.J. and CAMPBELL, K.H. (1997). Viable offspring derived from fetal and adult mammalian cells. Nature 385: 810-813.
60. WOLTJEN, K., MICHAEL, I.P., MOHSENI, P., DESAI, R., MILEIKOVSKY, M., HAMALAINEN, R., COWLING, R., WANG, W., LIU, P.T., GERTSENSTEIN, M. et al., (2009). piggyBac transposition reprograms fibroblasts to induced pluripotent stem cells. Nature 458: 766-U106.
61. WURM, F.M. (2004). Production of recombinant protein therapeutics in cultivated mammalian cells. Nat Biotechnol 22: 1393-1398.
62. YAKUBOV, E., RECHAVI, G., ROZENBLATT, S. and GIVOL, D. (2010). Reprogramming of human fibroblasts to pluripotent stem cells using mRNA of four transcription factors. Biochem Biophys Res Commun 394: 189-193.
63. YAMASAKI, S., NABESHIMA, K., SOTOMARU, Y., TAGUCHI, Y., MUKASA, H., FURUE, M.K., SATO, J.D. and OKAMOTO, T. (2013). Long-term serial cultivation of mouse induced pluripotent stem cells in serum-free and feeder-free defined medium. Int J Dev Biol 57: 715-724.
64. YANG, W.C., PATEL, K.G., LEE, J., GHEBREMARIAM, Y.T., WONG, H.E., COOKE, J.P. and SWARTZ, J.R. (2009). Cell-free production of transducible transcription factors for nuclear reprogramming. Biotechnol Bioeng 104: 1047-1058.
65. YU, J., HU, K., SMUGA-OTTO, K., TIAN, S., STEWART, R., SLUKVIN, II and THOMSON, J.A. (2009). Human induced pluripotent stem cells free of vector and transgene sequences. Science 324: 797-801.
66. ZHANG, H., MA, Y., GU, J., LIAO, B., LI, J., WONG, J. and JIN, Y. (2012). Reprogramming of somatic cells via TAT-mediated protein transduction of recombinant factors. Biomaterials 33: 5047-5055.
67. ZHANG, Y., WEI, C., ZHANG, P., LI, X., LIU, T., PU, Y., LI, Y., CAO, Z., CAO, H., LIU, Y. et al., (2014). Efficient Reprogramming of Naive-Like Induced Pluripotent Stem Cells from Porcine Adipose-Derived Stem Cells with a Feeder-Independent and Serum-Free System. PLoS One 9.
68. ZHAO, T., ZHANG, Z.N., RONG, Z. and XU, Y. (2011). Immunogenicity of induced pluripotent stem cells. Nature 474: 212-215.
69. ZHENG, Z., JIAN, J., ZHANG, X., ZARA, J.N., YIN, W., CHIANG, M., LIU, Y., WANG, J., PANG, S., TING, K. et al., (2012). Reprogramming of human fibroblasts into multipotent cells with a single ECM proteoglycan, fibromodulin. Biomaterials 33: 5821-5831.
70. ZHOU, H.Y., WU, S.L., JOO, J.Y., ZHU, S.Y., HAN, D.W., LIN, T.X., TRAUGER, S., BIEN, G., YAO, S., ZHU, Y. et al., (2009). Generation of Induced Pluripotent Stem Cells Using Recombinant Proteins. Cell Stem Cell 4: 381-384.
71. ZIEGLER, A., NERVI, P., DURRENBERGER, M. and SEELIG, J. (2005). The cationic cell-penetrating peptide CPP(TAT) derived from the HIV-1 protein TAT is rapidly transported into living fibroblasts: optical, biophysical, and metabolic evidence. Biochemistry 44: 138-148.